ReviewCell death & disease2024

The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies.

Puguang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.